Royal Bank of Canada’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2K | Sell |
|
|||||
|
2023
Q4 | $11K | Buy |
|
|||||
|
2023
Q3 | $10K | Buy |
|
|||||
|
2023
Q2 | $12K | Buy |
|
|||||
|
2023
Q1 | $14K | Sell |
|
|||||
|
2022
Q4 | $28K | Buy |
|
|||||
|
2022
Q3 | $41K | Buy |
|
|||||
|
2022
Q2 | $9K | Sell |
|
|||||
|
2022
Q1 | $36K | Sell |
|
|||||
|
2021
Q4 | $100K | Buy |
|
|||||
|
2021
Q3 | $60K | Buy |
|
|||||
|
2021
Q2 | $43K | Buy |
|
|||||
|
2021
Q1 | $48K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $11.5M | Sell |
|
|||||
|
2019
Q4 | $17.3M | Sell |
|
|||||
|
2019
Q3 | $16.7M | Sell |
|
|||||
|
2019
Q2 | $17.7M | Buy |
|